“The Biopharmaceuticals Excipients market is expected to grow at a CAGR of 12.2%” says new Visiongain report
15 April 2020
Visiongain has launched a new pharma report: Biopharmaceuticals Excipients Market 2020-2030: Triglycerides, Esters, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Specialty Biopharmaceutical Excipients & Others.
Pharmaceutical excipients (also known as bulking agent, filler, diluent) are substances formulated with the active ingredient of a drug. They are included in a pharmaceutical dosage form for a special purpose, such as to aid the manufacturing process and to support enhance stability of drugs. Excipients are also useful for product identification and for the enhancement of overall safety and functionality of the product during usage and storage.
The lead analyst of the report commented "Major factors fuelling growth in this market include overall growth in the biopharmaceutical industry and the increasing burden of chronic diseases which surges the demand for innovative and advanced drugs for treatment. The major challenge faced in this industry is the high cost of drug manufacturing, which is compounded by a strict regulatory environment. Government initiatives and increasing research in the development of innovative biopharmaceutical drugs are promising opportunities for market growth."
Leading companies featured in the report include ABITEC Corp, Signet Chemical Corporation, Roquette Freres SA, Sigachi Industries, MEGGLE AG & Other Companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.
About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Recent News
Visiongain Publishes AI-based Clinical Trial Solution Providers Market Report 2023-2033
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
26 May 2023
Read
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033
The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033
24 May 2023
Read
Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033
23 May 2023
Read
Visiongain Publishes Single-use Bioprocessing Probes & Sensors Market Report 2023-2033
The global Single-Use Bioprocessing Probes & Sensors market was valued US$2,493.8 million in 2022 and is projected to grow at a CAGR of 15.2% during the forecast period 2023-2033.